Innovation Sources For Medical Technology Begin Shift To Emerging Markets, But Large Capability Hurdles Remain - PwC Report
This article was originally published in PharmAsia News
Executive Summary
TOKYO - The U.S. has been the main source of medical technology innovation for many years, but the growing economies and technological capabilities of countries like China and India could soon shift the balance. The leading emerging markets are already making headway in becoming innovation leaders, although they will need to overcome large caveats that are stunting the development of innovative technologies
You may also be interested in...
Facing Tougher Competition At Home, China's Mindray Should Target Global Mid- To High-end Market, Analysts Say
Facing a new round of marketing campaigns from international device makers targeting China's low- to mid-end hospital markets, Shenzhen based Mindray Medical will be better off focusing instead on mid- to high-end global markets to stay competitive, analysts say
Government Funding Accelerates Venture Interest In China
HONG KONG - The growth in available government funding for pharmaceutical companies in China is creating a snowball of investment from domestic and multinational pharma companies more willing to overcome intellectual property concerns
China's Escalating Scientific Output Tempered By Quality Concerns
TOKYO - Much ink has been devoted to cover the explosion of scientific research being developed in China, but some in the pharma industry charged with identifying potential research partners are troubled with the quality of some research coming out of China